Literature DB >> 33440802

Hypertrophy and Insulin Resistance of Epicardial Adipose Tissue Adipocytes: Association with the Coronary Artery Disease Severity.

Natalia V Naryzhnaya1, Olga A Koshelskaya1, Irina V Kologrivova1, Olga A Kharitonova1, Vladimir V Evtushenko1, Alla A Boshchenko1.   

Abstract

Changes in the structural and functional characteristics of the epicardial adipose tissue (EAT) are recognized as one of the factors in the development of cardiometabolic diseases. However, the generally accepted quantitative assessment of the accumulation of EAT does not reflect the size of adipocyte and presence of adipocyte hypertrophy in this fat depot. Overall contribution of adipocyte hypertrophy to the development and progression of coronary atherosclerosis remains unexplored. Objective: To compare the morphological characteristics of EAT adipocyte and its sensitivity to insulin with the CAD severity, as well as to identify potential factors involved in the realization of this relationship. The present study involved 24 patients (m/f 16/8) aged 53-72 years with stable CAD, who underwent coronary artery bypass graft surgery. Adipocytes were isolated enzymatically from EAT explants obtained during the operation. The severity of CAD was assessed by calculating the Gensini score according to selective coronary angiography. Insulin resistance of EAT adipocytes was evaluated by reactivity to insulin. In patients with an average size of EAT adipocytes equal to or exceeding the median (87 μm) the percentage of hypertrophic adipocytes was twice as high as in patients in whom the average size of adipocytes was less than 87 μm. This group of patients was also characterized by the higher rate of the Gensini score, lower adiponectin levels, and more severe violation of carbohydrate metabolism. We have revealed direct nonparametric correlation between the size of EAT adipocytes and the Gensini score (rs = 0.56, p = 0.00047). The number of hypertrophic EAT adipocytes showed a direct nonparametric correlation with the Gensini score (rs = 0.6, p = 0.002). Inverse nonparametric correlations were found between the serum adiponectin level and size (rs = -0.60, p = 0.001), hypertrophy of adipocytes (rs = -0.67, p = 0.00), and Gensini score (rs = -0.81, p = 0.00007). An inverse nonparametric correlation was found between the Gensini score and sensitivity of EAT adipocytes to insulin, estimated by the intracellular redox response (rs = -0.90, p = 0.037) and decrease in lipolysis rate upon insulin addition (rs = -0.40, p = 0.05). The intracellular redox response of adipocytes to insulin was directly correlated with fasting insulin and inversely with postprandial insulin. Our data indicate that the size and degree of hypertrophy of the epicardial adipocytes are related to the CAD severity. According to our results, insulin resistance of adipocytes may be considered as one of the factors mediating this relationship.

Entities:  

Keywords:  CAD severity; adipokines; epicardial adipose tissue; hypertrophy of adipocytes; insulin resistance

Year:  2021        PMID: 33440802      PMCID: PMC7827040          DOI: 10.3390/biomedicines9010064

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  39 in total

1.  Mediastinal fat, insulin resistance, and hypertension.

Authors:  Arya M Sharma
Journal:  Hypertension       Date:  2004-07-12       Impact factor: 10.190

Review 2.  Epicardial adipose tissue feeding and overfeeding the heart.

Authors:  Gianluca Iacobellis; Giuseppe Barbaro
Journal:  Nutrition       Date:  2018-07-24       Impact factor: 4.008

3.  Ovine adipose tissue monounsaturated fat content is correlated to depot-specific expression of the stearoyl-CoA desaturase gene.

Authors:  M C Barber; R J Ward; S E Richards; A M Salter; P J Buttery; R G Vernon; M T Travers
Journal:  J Anim Sci       Date:  2000-01       Impact factor: 3.159

4.  Insulin-dependent metabolic and inotropic responses in the heart are modulated by hydrogen peroxide from NADPH-oxidase isoforms NOX2 and NOX4.

Authors:  Benjamin Steinhorn; Juliano L Sartoretto; Andrea Sorrentino; Natalia Romero; Hermann Kalwa; E Dale Abel; Thomas Michel
Journal:  Free Radic Biol Med       Date:  2017-09-14       Impact factor: 7.376

5.  Epicardial adipose tissue and insulin resistance in obese subjects.

Authors:  Gianluca Iacobellis; Frida Leonetti
Journal:  J Clin Endocrinol Metab       Date:  2005-08-09       Impact factor: 5.958

6.  A more meaningful scoring system for determining the severity of coronary heart disease.

Authors:  G G Gensini
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

7.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction.

Authors:  Gianluca Iacobellis; Filippo Assael; Maria Cristina Ribaudo; Alessandra Zappaterreno; Giuseppe Alessi; Umberto Di Mario; Frida Leonetti
Journal:  Obes Res       Date:  2003-02

8.  Relationship between the Echocardiographic Epicardial Adipose Tissue Thickness and Serum Adiponectin in Patients with Angina.

Authors:  Kyeong Ho Yun; Sang Jae Rhee; Nam Jin Yoo; Seok Kyu Oh; Nam-Ho Kim; Jin-Won Jeong; Do-Sim Park; Hyun-Young Park
Journal:  J Cardiovasc Ultrasound       Date:  2009-12-31

Review 9.  Causes and mechanisms of adipocyte enlargement and adipose expansion.

Authors:  F Haczeyni; K S Bell-Anderson; G C Farrell
Journal:  Obes Rev       Date:  2017-12-15       Impact factor: 9.213

10.  Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability.

Authors:  Esther Díaz-Rodríguez; Rosa M Agra; Ángel L Fernández; Belén Adrio; Tomás García-Caballero; José R González-Juanatey; Sonia Eiras
Journal:  Cardiovasc Res       Date:  2018-02-01       Impact factor: 10.787

View more
  8 in total

Review 1.  Assessing Obesity-Related Adipose Tissue Disease (OrAD) to Improve Precision Medicine for Patients Living With Obesity.

Authors:  Yair Pincu; Uri Yoel; Yulia Haim; Nataly Makarenkov; Nitzan Maixner; Ruthy Shaco-Levy; Nava Bashan; Dror Dicker; Assaf Rudich
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

2.  Identifying sex differences in predictors of epicardial fat cell morphology.

Authors:  Helen M M Waddell; Matthew K Moore; Morgan A Herbert-Olsen; Martin K Stiles; Rexson D Tse; Sean Coffey; Regis R Lamberts; Hamish M Aitken-Buck
Journal:  Adipocyte       Date:  2022-12       Impact factor: 3.553

3.  Association of High Serum Adiponectin Level With Adverse Cardiovascular Outcomes and Progression of Coronary Artery Calcification in Patients With Pre-dialysis Chronic Kidney Disease.

Authors:  Sang Heon Suh; Tae Ryom Oh; Hong Sang Choi; Chang Seong Kim; Joongyub Lee; Yun Kyu Oh; Ji Yong Jung; Kyu-Beck Lee; Kook-Hwan Oh; Seong Kwon Ma; Eun Hui Bae; Soo Wan Kim
Journal:  Front Cardiovasc Med       Date:  2022-01-13

Review 4.  PPARγ-A Factor Linking Metabolically Unhealthy Obesity with Placental Pathologies.

Authors:  Sebastian Kwiatkowski; Anna Kajdy; Katarzyna Stefańska; Magdalena Bednarek-Jędrzejek; Sylwia Dzidek; Piotr Tousty; Małgorzata Sokołowska; Ewa Kwiatkowska
Journal:  Int J Mol Sci       Date:  2021-12-06       Impact factor: 5.923

5.  Special Issue: Emerging Paradigms in Insulin Resistance.

Authors:  J Jason Collier; Susan J Burke
Journal:  Biomedicines       Date:  2022-06-22

6.  Production of Reactive Oxygen Species by Epicardial Adipocytes Is Associated with an Increase in Postprandial Glycemia, Postprandial Insulin, and a Decrease in Serum Adiponectin in Patients with Severe Coronary Atherosclerosis.

Authors:  Natalia V Naryzhnaya; Olga A Koshelskaya; Irina V Kologrivova; Tatiana E Suslova; Olga A Kharitonova; Sergey L Andreev; Alexander S Gorbunov; Boris K Kurbatov; Alla A Boshchenko
Journal:  Biomedicines       Date:  2022-08-22

Review 7.  Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review.

Authors:  Michał Konwerski; Aleksandra Gąsecka; Grzegorz Opolski; Marcin Grabowski; Tomasz Mazurek
Journal:  Biology (Basel)       Date:  2022-02-23

Review 8.  Molecular biochemical aspects of salt (sodium chloride) in inflammation and immune response with reference to hypertension and type 2 diabetes mellitus.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2021-08-01       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.